• Anti-ROR1 Antibody (Zilovertamab): Redefining Liver Injury M

  2026-05-18

  Explore how Anti-ROR1 Antibody (Zilovertamab) advances Wnt5a-induced ROR1 signaling inhibition in mycotoxin-induced liver injury models. This article uniquely bridges mechanistic antibody action with practical assay design for cancer and toxicology research.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Applied

  2026-05-18

  PYR-41, the selective inhibitor of Ubiquitin-Activating Enzyme E1 from APExBIO, enables precise dissection of the ubiquitin-proteasome system and NF-κB signaling in both cellular and animal models. This guide delivers actionable protocols, troubleshooting tips, and cross-domain insights for leveraging PYR-41 in proteostasis, inflammation, and viral-host interaction studies.

• LY-411575: Precision Gamma-Secretase Inhibitor for Alzheimer

  2026-05-17

  LY-411575 stands out as a potent, selective gamma-secretase inhibitor, enabling researchers to dissect amyloid beta production and Notch signaling with exceptional specificity. This guide delivers stepwise experimental workflows, actionable troubleshooting, and comparative insights to maximize the translational impact of LY-411575 in Alzheimer’s and cancer research.

• Dextromethorphan Hydrobromide: New Horizons in Neuroprotecti

  2026-05-16

  This article explores the advanced scientific rationale and translational strategy behind using Dextromethorphan hydrobromide as a research tool in neuroprotection and excitotoxicity inhibition. We bridge preclinical mechanistic insights with practical guidance for translational neuroscience teams, incorporating competitive context, evidence-driven protocol design, and a forward-looking outlook. The discussion is enriched by reference to recent advances in metabolic disease targeting and highlights how APExBIO’s high-purity Dextromethorphan hydrobromide enables robust, reproducible research.

• Chemically Modified SOD2 mRNA-LNPs Mitigate Renal Ischemia-R

  2026-05-15

  This study demonstrates that lipid nanoparticle-mediated delivery of chemically modified SOD2 mRNA alleviates renal ischemia-reperfusion injury in mice by reducing mitochondrial reactive oxygen species and restoring kidney function. The work provides a mechanistic advance for mRNA therapeutics in acute kidney injury, with implications for optimized mRNA delivery and reporter assay design.

• Iptacopan Monotherapy in PNH: Rapid Hemolysis Control via Or

  2026-05-15

  This study demonstrates that oral Iptacopan (LNP023) monotherapy achieves rapid and sustained control of hemolysis, hemoglobin normalization, and reduced transfusion needs in treatment-naïve paroxysmal nocturnal hemoglobinuria (PNH) patients. The findings establish oral alternative pathway inhibition as a clinically meaningful alternative to existing monoclonal antibody therapies, highlighting the value of targeted complement factor B blockade.

• Remdesivir (GS-5734): Strategic Leverage in RNA Virus Resear

  2026-05-14

  This thought-leadership article explores the mechanistic foundations and strategic opportunities for translational researchers leveraging Remdesivir (GS-5734) in emerging RNA virus research. Integrating structural insights from Nipah virus polymerase studies with experimental benchmarks for coronavirus and Ebola virus inhibition, it offers evidence-based guidance on assay selection, workflow optimization, and pipeline positioning. The discussion highlights how Remdesivir distinguishes itself as a versatile chemical probe and translational candidate, and provides a forward-looking assessment of cross-viral antiviral targeting.

• CFTRinh-172: Precision CFTR Inhibitor Workflows & Troublesho

  2026-05-14

  CFTRinh-172 empowers researchers to dissect CFTR chloride channel activity with rapid, selective inhibition. This guide translates recent breakthroughs in CFTR trafficking into actionable protocols, troubleshooting strategies, and comparative insights for cystic fibrosis and secretory diarrhea research.

• Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Comp

  2026-05-13

  The Protein A/G Magnetic Co-IP/IP Kit leverages recombinant Protein A/G magnetic beads for rapid, high-specificity co-immunoprecipitation and antibody purification. Its streamlined protocol minimizes protein degradation and enhances reproducibility, making it ideal for advanced protein-protein interaction studies in disease mechanisms like IVDD.

• Tetrahydromagnolol in Peripheral CB2 Receptor Agonist Workfl

  2026-05-13

  Tetrahydromagnolol, a highly selective peripheral CB2 receptor agonist, uniquely enables precise dissection of cannabinoid signaling and anti-inflammatory pathways. Its dual role as a CB2 agonist and GPR55 antagonist elevates assay specificity and reproducibility for advanced cannabinoid receptor research.

• Indomethacin: NSAID Mechanism, Cox-1 Selectivity and Researc

  2026-05-12

  Indomethacin is a nonsteroidal anti-inflammatory drug with Cox-1 selectivity, PPAR agonist activity, and membrane-modulating effects. It is instrumental for inflammation and lipid metabolism research, with well-characterized solubility and storage specifications. This dossier clarifies its validated utility and common misconceptions.

• Otilonium Bromide: Antimuscarinic Agent in Advanced Research

  2026-05-12

  Otilonium Bromide stands out as a high-purity antimuscarinic agent, enabling robust modeling of cholinergic signaling in neuroscience and smooth muscle assays. This guide dissects applied workflows, comparative strengths, and expert troubleshooting for reproducible, data-driven experimentation.

• Phosphatase Inhibitor Cocktail 1: Precision in B Cell Signal

  2026-05-11

  Explore the pivotal role of Phosphatase Inhibitor Cocktail 1 in preserving protein phosphorylation, with a unique focus on B cell signaling pathways. This in-depth analysis reveals how optimized inhibitor use enables robust phosphoproteomic studies and advances immuno-oncology research.

• Baicalin Methyl Ester: Advanced Strategies for Intestinal Ba

  2026-05-11

  Discover how Baicalin methyl ester, an esterified derivative of baicalin, advances LPS-induced intestinal barrier damage research through precise pathway modulation and superior anti-inflammatory action. This in-depth analysis bridges molecular mechanisms and practical assay strategies for translational teams.

• Brefeldin A in Cancer and Endothelial Research: Applied Work

  2026-05-10

  Brefeldin A (BFA) is a gold-standard tool for dissecting ER–Golgi trafficking, ER stress, and programmed cell death in oncology and vascular studies. This article delivers actionable protocols, troubleshooting strategies, and insights from recent biomarker research, maximizing experimental precision with APExBIO’s BFA.

16693 records 7/1113 page Previous Next First page 上5页 678910 下5页 Last page